NIOX Group (LON:NIOX) Insider Sells £3,059.20 in Stock

NIOX Group Plc (LON:NIOX) insider Sarah Duncan sold 3,824 shares of the business’s stock in a transaction on Tuesday, October 27th. The shares were sold at an average price of GBX 80, for a total transaction of £3,059.20.

NIOX Group Trading Up 2.6%

NIOX Group stock opened at GBX 64 on Friday. The company’s fifty day simple moving average is GBX 67.09 and its 200-day simple moving average is GBX 63.06. The company has a quick ratio of 1.94, a current ratio of 4.60 and a debt-to-equity ratio of 1.06. NIOX Group Plc has a 12 month low of GBX 53.84 and a 12 month high of GBX 80. The stock has a market cap of £259.35 million, a P/E ratio of 39.26 and a beta of 0.92.

NIOX Group (LON:NIOX) last announced its quarterly earnings results on Wednesday, September 30th. The company reported GBX 1.41 EPS for the quarter. NIOX Group had a net margin of 14.74% and a return on equity of 10.01%. As a group, sell-side analysts forecast that NIOX Group Plc will post 1.17 EPS for the current fiscal year.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.